ReviewBiochimie2020

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

Pierre-Jean Ferron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.